Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000085

President and CEO sold 2,376 shares at an average $49.57 ($117,769)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-19 Sale : show line 1 in the form −1,626 $49.38 $80,292 2,177,450 I
2021-08-19 Sale : show line 2 in the form −750 $49.97 $37,478 2,176,700 I
Open-market sales · 2,376 sh · avg $49.57 · $117,769
Loading xslF345X03/wf-form4_162976467767655.xml…